
Profitability, historical returns, and peer comparisons.
According to Dr. Reddy's Laboratories Limited’s latest financial reports and current stock price. The company's current ROE is 7.37%. This represents a change of 299.15% compared to the average of 1.85% of the last 4 quarters.
The mean historical ROE of Dr. Reddy's Laboratories Limited over the last ten years is 13.35%. The current 7.37% ROE has changed -44.79% with respect to the historical average. Over the past ten years (40 quarters), RDY's ROE was at its highest in in the September 2019 quarter at 7.10%. The ROE was at its lowest in in the December 2019 quarter at -3.83%.
Average
13.35%
Median
12.48%
Minimum
7.75%
Maximum
19.85%
Discovering the peaks and valleys of Dr. Reddy's Laboratories Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 72.89%
Maximum Annual ROE = 19.85%
Minimum Annual Increase = -37.76%
Minimum Annual ROE = 7.75%
| Year | ROE | Change |
|---|---|---|
| 2026 | 11.36% | -33.00% |
| 2025 | 16.96% | -14.55% |
| 2024 | 19.85% | 1.73% |
| 2023 | 19.51% | 57.72% |
| 2022 | 12.37% | 24.19% |
| 2021 | 9.96% | -20.82% |
| 2020 | 12.58% | -6.16% |
| 2019 | 13.41% | 72.89% |
| 2018 | 7.75% | -20.10% |
| 2017 | 9.71% | -37.76% |
The current ROE of Dr. Reddy's Laboratories Limited (RDY) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
16.06%
5-year avg
16.01%
10-year avg
13.35%
Dr. Reddy's Laboratories Limited’s ROE is greater than Viatris Inc. (-2.79%), less than Amneal Pharmaceuticals, Inc. (131.71%), less than Teva Pharmaceutical Industries Limited (6.35%), less than Bausch Health Companies Inc. (58.90%), less than Amphastar Pharmaceuticals, Inc. (10.11%), less than ANI Pharmaceuticals, Inc. (19.19%), less than Haleon plc (9.89%), less than Sun Pharmaceutical Industries Limited (13.10%), less than Cipla Limited (8.44%), less than Mankind Pharma Limited (13.60%),
| Company | ROE | Market cap |
|---|---|---|
| -2.79% | $22.08B | |
| 131.71% | $6.95B | |
| 6.35% | $48.77B | |
| 58.90% | $3.12B | |
| 10.11% | $1.19B | |
| 19.19% | $1.65B | |
| 9.89% | $40.59B | |
| 13.10% | $4.25T | |
| 8.44% | $1.13T | |
| 13.60% | $1.05T |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Dr. Reddy's Laboratories Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Dr. Reddy's Laboratories Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Dr. Reddy's Laboratories Limited's ROE?
How is the ROE calculated for Dr. Reddy's Laboratories Limited (RDY)?
What is the highest ROE for Dr. Reddy's Laboratories Limited (RDY)?
What is the 3-year average ROE for Dr. Reddy's Laboratories Limited (RDY)?
What is the 5-year average ROE for Dr. Reddy's Laboratories Limited (RDY)?
How does the current ROE for Dr. Reddy's Laboratories Limited (RDY) compare to its historical average?